PCLO — Pharmacielo Cashflow Statement
0.000.00%
Last trade - 00:00- CA$11.05m
- CA$29.19m
- CA$2.54m
Annual cashflow statement for Pharmacielo, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 15 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -26.6 | -14.5 | -16.3 | -11.4 | -3.58 |
| Depreciation | |||||
| Non-Cash Items | 12.9 | 4.85 | 7.52 | 6.55 | 0.031 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -7.58 | -1.79 | 2.22 | 1.07 | -1.81 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -20.1 | -9.88 | -5.15 | -2.11 | -4.61 |
| Capital Expenditures | -1.14 | -0.522 | -0.015 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.519 | -0.036 | 0.407 | 0.041 | 10 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.66 | -0.558 | 0.392 | 0.041 | 10 |
| Financing Cash Flow Items | -1.28 | 0.04 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 18.2 | 5.3 | 4.63 | 2.06 | -5.44 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.52 | -5.17 | -0.111 | -0.008 | -0.037 |